Sorrento Therapeutics Inc (SRNE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0010 unch (unch) 04/04/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0010 unch (unch) 13:31 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,634 | 36,665 | 56,464 | 35,619 | 168,330 |
| Marketable Securities | 26,344 | 90,217 | N/A | N/A | N/A |
| Receivables | 24,469 | 18,715 | 15,506 | 14,454 | 4,359 |
| Inventories | 9,976 | 8,106 | 1,831 | 3,362 | 2,898 |
| Other current assets | 3,143 | 7,482 | 3,721 | 2,403 | 0 |
| TOTAL | $96,373 | $172,989 | $86,234 | $67,588 | $179,564 |
| Non-Current Assets | |||||
| PPE Net | 51,971 | 41,325 | 31,861 | 29,888 | 24,384 |
| Investments And Advances | 17,176 | 51,271 | 256,397 | 262,241 | 27,980 |
| Intangibles | 217,171 | 339,230 | 117,229 | 101,606 | 104,581 |
| Other Non-Current Assets | 90,149 | 90,003 | 44,101 | 96,309 | 287,578 |
| TOTAL | $376,467 | $521,829 | $449,588 | $490,044 | $444,523 |
| Total Assets | $472,840 | $694,818 | $535,822 | $557,632 | $624,087 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,286 | 31,980 | 23,208 | 36,261 | 10,150 |
| Accounts payable and accrued liabilities | 55,315 | 34,951 | 25,104 | 44,452 | 25,129 |
| Accrued Expenses | 241,392 | 59,478 | 40,057 | 18,728 | 23,639 |
| Other current liabilities | 397 | 397 | N/A | 8,800 | N/A |
| TOTAL | $327,922 | $139,453 | $96,480 | $115,206 | $61,621 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,130 | 110,627 | 92,258 | 199,088 | 223,136 |
| Deferred Revenues | 652 | 1,108 | 4,485 | 3,643 | 2,703 |
| aiOther Non-Current Liabilities | 144,682 | 246,054 | 102,199 | 158,094 | 15,126 |
| TOTAL | $166,587 | $477,236 | $298,611 | $409,670 | $354,966 |
| Total Liabilities | $494,509 | $616,689 | $395,091 | $524,876 | $416,587 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 551,281 | 342,335 | 280,323 | 181,340 | 122,280 |
| Common Shares | 52 | 32 | 28 | 18 | 13 |
| Retained earnings | -1,959,447 | -1,386,604 | -958,279 | -659,818 | -367,750 |
| Other shareholders' equity | -2,027 | -57 | -24,364 | -46,566 | -2,421 |
| TOTAL | $-21,669 | $78,129 | $140,731 | $32,756 | $207,500 |
| Total Liabilities And Equity | $472,840 | $694,818 | $535,822 | $557,632 | $624,087 |